Download PDF
1 / Pages

Other users also viewed these articles

Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study Roxana González Mazarío; Jorge Juan Fragío Gil; José Ivorra Cortés; Elena Grau García; Antonio José Cañada Martínez; Luis González Puig; Rosa María Negueroles Albuixech; José Andrés Román Ivorra;
Reumatol Clin. 2022;18:523-30
Recurrent pericarditis after Covid-19 David Rodrigo Domínguez; Amalia Rueda Cid; Cristina Campos Fernández; Clara Molina Almela; Juan José Lerma Garrido; M. Dolores Pastor Cubillo;
Reumatol Clin. 2022;18:435-6